Deutsche Bank Aktiengesellschaft Forecasts Strong Price Appreciation for Bath & Body Works (NYSE:BBWI) Stock

Bath & Body Works (NYSE:BBWI) had its target price increased by Deutsche Bank Aktiengesellschaft from $51.00 to $52.00 in a report issued on Tuesday,Benzinga reports. The firm currently has a buy rating on the stock.

Other equities research analysts have also issued research reports about the company. The Goldman Sachs Group lowered their price objective on Bath & Body Works from $60.00 to $49.00 and set a “buy” rating on the stock in a report on Thursday, August 29th. Piper Sandler lifted their price target on Bath & Body Works from $35.00 to $36.00 and gave the company a “neutral” rating in a research note on Tuesday. Bank of America dropped their price objective on Bath & Body Works from $54.00 to $45.00 and set a “buy” rating on the stock in a report on Thursday, August 29th. Barclays boosted their target price on shares of Bath & Body Works from $28.00 to $34.00 and gave the stock an “underweight” rating in a research report on Tuesday. Finally, Robert W. Baird cut their price target on shares of Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating for the company in a report on Thursday, August 29th. One investment analyst has rated the stock with a sell rating, six have given a hold rating and nine have issued a buy rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $41.88.

Bath & Body Works Stock Performance

Shares of NYSE:BBWI opened at $35.23 on Tuesday. Bath & Body Works has a one year low of $26.20 and a one year high of $52.99. The stock has a market capitalization of $7.72 billion, a price-to-earnings ratio of 8.53, a PEG ratio of 0.98 and a beta of 1.79. The company has a 50-day simple moving average of $30.69 and a 200-day simple moving average of $35.74.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings results on Wednesday, August 28th. The company reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.02. Bath & Body Works had a negative return on equity of 41.94% and a net margin of 12.69%. The firm had revenue of $1.53 billion during the quarter, compared to the consensus estimate of $1.54 billion. As a group, research analysts forecast that Bath & Body Works will post 3.18 EPS for the current fiscal year.

Bath & Body Works Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Friday, November 22nd will be given a dividend of $0.20 per share. The ex-dividend date is Friday, November 22nd. This represents a $0.80 annualized dividend and a dividend yield of 2.27%. Bath & Body Works’s dividend payout ratio is currently 19.37%.

Insider Buying and Selling at Bath & Body Works

In other news, CEO Gina Boswell bought 6,000 shares of the business’s stock in a transaction that occurred on Wednesday, October 9th. The stock was purchased at an average price of $29.64 per share, with a total value of $177,840.00. Following the purchase, the chief executive officer now owns 242,987 shares of the company’s stock, valued at $7,202,134.68. This trade represents a 2.53 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available through this link. 0.27% of the stock is owned by insiders.

Institutional Investors Weigh In On Bath & Body Works

A number of hedge funds and other institutional investors have recently modified their holdings of BBWI. First Community Trust NA acquired a new stake in shares of Bath & Body Works during the second quarter worth $30,000. True Wealth Design LLC lifted its position in Bath & Body Works by 5,270.0% during the third quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock worth $34,000 after buying an additional 1,054 shares during the period. Livforsakringsbolaget Skandia Omsesidigt boosted its stake in Bath & Body Works by 300.0% in the 3rd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock worth $38,000 after buying an additional 900 shares during the last quarter. Wilmington Savings Fund Society FSB purchased a new stake in Bath & Body Works in the 3rd quarter valued at about $39,000. Finally, TD Private Client Wealth LLC grew its holdings in Bath & Body Works by 24.2% in the 3rd quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock valued at $54,000 after buying an additional 331 shares during the period. 95.14% of the stock is currently owned by hedge funds and other institutional investors.

Bath & Body Works Company Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.